SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX)
NBIX 141.80+0.6%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (369)12/23/1999 9:16:00 PM
From: Mike McFarland  Read Replies (1) of 1834
 
What would you say if I suggested that the
move in Neurocrine, apparently up to a more
reasonable valuation, was in a very large part
due to Vector and BBRS getting the word out
months ago, and that half of the move was
merely momentum joining in?

The SI biogurus (of which I am an enthusiastic
groupie) are surprisingly good at finding extreme
biotech values--however that post of yours had
a little whiff of 'we can do this all without you'.
And that may be true--but I assume these fellas,
BBRS, Vector, can move stocks primarily because they
have clients who have a lot of money, and have not
even heard of Silicon Investor.

Just a thought, not a huge criticism.
Just always overeager to share the first thing
that pops into my head when I read your posts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News